NCT07532213 A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab Status NOT_YET_RECRUITING Phase N/A
NCT07475052 Continuous HRV Monitoring for Predicting Response to Biologic Therapy in IBD Status ENROLLING_BY_INVITATION Phase N/A
NCT07391046 Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients Status NOT_YET_RECRUITING Phase N/A
NCT07242248 A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK) Status RECRUITING Phase N/A
NCT07210580 Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease Status RECRUITING Phase NA
NCT07167836 Automated Clinical Pathway for Inflammatory Bowel Disease Care Status ENROLLING_BY_INVITATION Phase NA
NCT07167745 Tracking the Natural Course of Silent Small Bowel Narrowing in Adults With Crohn's Disease Status COMPLETED Phase N/A
NCT07143188 The EDICT Trial - Therapy for Inflammatory Bowel Disease Flares Status NOT_YET_RECRUITING Phase NA
NCT07102368 A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany Status RECRUITING Phase N/A
NCT06781827 Research on the Use of Probiotics in the Prevention and Treatment of Inflammatory Bowel Disease Status RECRUITING Phase NA
NCT06780683 Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease Status RECRUITING Phase N/A
NCT06623383 Correlation of Fecal Calprotectin and Fecal Immunochemical Test in Determination of Endoscopic Activity in Inflammatory Bowel Disease Patients Status COMPLETED Phase N/A
NCT06599658 COVID-19 Booster and IIV Schedule in Immunocompromised Hosts Status RECRUITING Phase PHASE2
NCT06483373 A Clinical Study of SPH7854 Granules in Healthy Subjects. Status RECRUITING Phase EARLY_PHASE1
NCT06405503 Impact of Primary Language on Treatment and Outcomes in Inflammatory Bowel Disease Status NOT_YET_RECRUITING Phase N/A
NCT06346288 A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel Disease Status COMPLETED Phase PHASE4